We observed moderate increase in the proportion of the cells in G0/G1 cell cycle phase after rhTGF-β1 exposure in all primary AML samples, which was more prominent in the presence of MSCs irrespective of FLT3 status (8/10 cases; Pt #1,2,5–10). The gene discussed is FLT3; the disease is acute myeloid leukemia.